The administrative and financial framework, with rules for application and project implementation, of Horizon Europe calls are set-out in a Grant Agreement; the Annotated Model Grant Agreement explains extensively all details.
ann.vanhauwaert@fwo.be
+32 2 550 15 60
Ria.debreucker@vlaio.be
+32 2 553 13 77
Horizon Europe HorizonEU L+F H2020 L+F
The Commission published their recent report based on analysis of implementation data and feedback from surveys. According to the Commission, the new report confirms that: ·lump sum funding continues to be popular with users ·lump sums are perceived as reducing the administrative burden ·concerns of some stakeholder... read more
Horizon Europe HorizonEU L+F Digital Europe Defence
Ethics and security play an important role in applications for projects under Horizon Europe, Digital Europe and the EU Defence Fund. Consortia submitting proposals are expected to self-reflect on ethics issues, followed by screenings and follow-ups by the European Commission. For certain calls under the three programmes, participation can be res... read more
Enhancing EU R&I HorizonEU L+F
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.